• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ketamine and Esketamine for Depression in Daily Practice: Opportunities and Challenges.

作者信息

Singh Balwinder

机构信息

From the Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.

出版信息

J Clin Psychopharmacol. 2024;44(5):451-455. doi: 10.1097/JCP.0000000000001898. Epub 2024 Aug 22.

DOI:10.1097/JCP.0000000000001898
PMID:39173027
Abstract
摘要

相似文献

1
Ketamine and Esketamine for Depression in Daily Practice: Opportunities and Challenges.氯胺酮和艾司氯胺酮在日常临床中治疗抑郁症：机遇与挑战
J Clin Psychopharmacol. 2024;44(5):451-455. doi: 10.1097/JCP.0000000000001898. Epub 2024 Aug 22.
2
Intravenous (IV) ketamine versus intranasal esketamine for depression- Advantage IV ketamine?静脉注射氯胺酮与鼻内给予艾司氯胺酮治疗抑郁症——静脉注射氯胺酮的优势？
J Affect Disord. 2024 Jul 1;356:564-567. doi: 10.1016/j.jad.2024.04.088. Epub 2024 Apr 22.
3
Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.管理 Esketamine 治疗频率以实现成功治疗结果：3 期数据分析。
Int J Neuropsychopharmacol. 2020 Jul 29;23(7):426-433. doi: 10.1093/ijnp/pyaa027.
4
A new indication for esketamine nasal spray (Spravato).艾氯胺酮鼻喷雾剂（Spravato）的一项新适应症。
Med Lett Drugs Ther. 2020 Sep 21;62(1607):151.
5
Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment.依他佐辛鼻喷雾剂附加治疗与附加第二代抗精神病药物治疗对难治性重度抑郁症的治疗反应。
Int J Neuropsychopharmacol. 2020 Jul 29;23(7):440-445. doi: 10.1093/ijnp/pyaa034.
6
Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis.依他佐辛增效治疗重性抑郁障碍的疗效：一项荟萃分析。
J Clin Psychiatry. 2020 May 26;81(4):19r12889. doi: 10.4088/JCP.19r12889.
7
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.总结氯胺酮和艾司氯胺酮治疗难治性抑郁症的证据：现有证据和实施情况的国际专家意见。
Am J Psychiatry. 2021 May 1;178(5):383-399. doi: 10.1176/appi.ajp.2020.20081251. Epub 2021 Mar 17.
8
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I).依他佐辛鼻喷剂用于有自杀意念的重性抑郁障碍患者快速减轻症状的双盲随机研究（ASPIRE I）。
J Clin Psychiatry. 2020 May 12;81(3):19m13191. doi: 10.4088/JCP.19m13191.
9
Esketamine for treatment resistant depression: a trick of smoke and mirrors?用于治疗抵抗性抑郁症的 Esketamine：烟雾与镜子的把戏？
Epidemiol Psychiatr Sci. 2019 Dec 16;29:e79. doi: 10.1017/S2045796019000751.
10
Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis.静脉注射氯胺酮和鼻内依他佐辛递增剂量治疗重度抑郁症的疗效：系统评价和荟萃分析。
J Affect Disord. 2024 Jul 1;356:379-384. doi: 10.1016/j.jad.2024.03.137. Epub 2024 Mar 26.

引用本文的文献

1
Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine: An Observational Study.接受静脉注射氯胺酮和鼻内艾司氯胺酮治疗的难治性抑郁症患者的长期结局：一项观察性研究。
J Clin Psychiatry. 2025 Jul 30;86(3):25m15831. doi: 10.4088/JCP.25m15831.
2
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression.高基线血浆邻氨基苯甲酸可预测难治性抑郁症急性系列氯胺酮输注后的缓解情况。
Biol Psychiatry Glob Open Sci. 2025 Apr 12;5(4):100503. doi: 10.1016/j.bpsgos.2025.100503. eCollection 2025 Jul.
3
Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression.
基线感知压力作为难治性抑郁症中氯胺酮/艾氯胺酮治疗反应的预测指标。
J Affect Disord. 2025 Aug 15;383:283-289. doi: 10.1016/j.jad.2025.04.117. Epub 2025 Apr 25.
4
Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder.双相情感障碍药物治疗的全球使用趋势
Curr Psychiatry Rep. 2025 May;27(5):239-247. doi: 10.1007/s11920-025-01606-8. Epub 2025 Mar 27.
5
MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: Regulatory Challenges and a Path Forward.摇头丸辅助治疗创伤后应激障碍：监管挑战与前进之路
CNS Drugs. 2025 Apr;39(4):339-343. doi: 10.1007/s40263-025-01162-y. Epub 2025 Feb 15.
6
Noncardiac Chest Pain and Hypertensive Urgency During Long-term Intravenous Racemic Ketamine for Treatment-Resistant Depression.长期静脉输注消旋氯胺酮治疗难治性抑郁症期间的非心源性胸痛和高血压急症
J Clin Psychopharmacol. 2025;45(1):49-52. doi: 10.1097/JCP.0000000000001939. Epub 2024 Nov 18.